Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Signaling: cellular insights into the pathophysiology of bipolar disorder.

Manji HK, Lenox RH.

Biol Psychiatry. 2000 Sep 15;48(6):518-30. Review.

PMID:
11018224
2.
3.

Neurobiology of lithium: an update.

Lenox RH, McNamara RK, Papke RL, Manji HK.

J Clin Psychiatry. 1998;59 Suppl 6:37-47. Review.

4.

Overview of the mechanism of action of lithium in the brain: fifty-year update.

Lenox RH, Hahn CG.

J Clin Psychiatry. 2000;61 Suppl 9:5-15. Review.

5.

The nature of bipolar disorder.

Manji HK, Lenox RH.

J Clin Psychiatry. 2000;61 Supp 13:42-57. Review.

6.

Signal transduction pathways. Molecular targets for lithium's actions.

Manji HK, Potter WZ, Lenox RH.

Arch Gen Psychiatry. 1995 Jul;52(7):531-43. Review.

PMID:
7598629
7.

Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.

Hahn CG, Friedman E.

Bipolar Disord. 1999 Dec;1(2):81-6. Review.

PMID:
11252663
8.

[Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].

Einat H, Chen G, Manji H.

Harefuah. 2004 Jun;143(6):420-5, 462. Review. Hebrew.

PMID:
15524099
10.

Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.

Quiroz JA, Singh J, Gould TD, Denicoff KD, Zarate CA, Manji HK.

Mol Psychiatry. 2004 Aug;9(8):756-76. Review.

PMID:
15136795
11.

Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium.

Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT.

Brain Res Bull. 2001 Jul 15;55(5):625-9.

PMID:
11576759
12.

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.

Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK.

Mol Psychiatry. 2004 Aug;9(8):734-55. Review.

PMID:
15136794
13.

[Physiopathology of bipolar disorders: what have changed in the last 10 years?].

Kapczinski F, Frey BN, Zannatto V.

Rev Bras Psiquiatr. 2004 Oct;26 Suppl 3:17-21. Epub 2004 Dec 7. Review. Portuguese.

14.

[Neuropatological and neurochemical abnormalities in bipolar disorder].

Frey BN, Fonseca MM, Machado-Vieira R, Soares JC, Kapczinski F.

Rev Bras Psiquiatr. 2004 Sep;26(3):180-8. Epub 2004 Nov 17. Review. Portuguese.

15.

Neurobiology of bipolar illness: implications for future study and therapeutics.

Post RM, Speer AM, Hough CJ, Xing G.

Ann Clin Psychiatry. 2003 Jun;15(2):85-94. Review.

PMID:
12938866
16.

Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes.

Stoll AL, Severus WE.

Harv Rev Psychiatry. 1996 Jul-Aug;4(2):77-89.

PMID:
9384977
17.

Postreceptor pathways for signal transduction in depression and bipolar disorder.

Young LT.

J Psychiatry Neurosci. 2001;26 Suppl:S17-22. Review.

18.
19.

Possible involvement of the ERK signaling cascade in bipolar disorder: behavioral leads from the study of mutant mice.

Einat H, Manji HK, Gould TD, Du J, Chen G.

Drug News Perspect. 2003 Sep;16(7):453-63. Review.

PMID:
14668941
20.

Supplemental Content

Support Center